The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study

BACKGROUND: It was controversial that whether LUAD patients with brain metastases (BMs) and EGFR sensitive mutations should be conducted using brain radiotherapy when treated with first-generation EGFR-TKI. Herein, a retrospective study was designed to compare the efficacy of first-generation EGFR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuting, Wang, Juanjuan, Wu, Jingjing, Yang, Qifan, Zeng, Yulan, Wu, Di, Tian, Chen, Hu, Yue, Gu, Feifei, Li, Chang, Zhang, Kai, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958186/
https://www.ncbi.nlm.nih.gov/pubmed/33715525
http://dx.doi.org/10.1177/1533033821997819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958186/
https://www.ncbi.nlm.nih.gov/pubmed/33715525
http://dx.doi.org/10.1177/1533033821997819

Ejemplares similares